Abnormalities of the type I interferon signaling pathway in lupus autoimmunity
S Gallucci, S Meka, AM Gamero - Cytokine, 2021 - Elsevier
Type I interferons (IFNs), mostly IFNα and IFNβ, and the type I IFN Signature are important in
the pathogenesis of Systemic Lupus Erythematosus (SLE), an autoimmune chronic …
the pathogenesis of Systemic Lupus Erythematosus (SLE), an autoimmune chronic …
Signaling pathways of type I and type III interferons and targeted therapies in systemic lupus erythematosus
IT Chyuan, HT Tzeng, JY Chen - Cells, 2019 - mdpi.com
Type I and type III interferons (IFNs) share several properties in common, including the
induction of signaling pathways, the activation of gene transcripts, and immune responses …
induction of signaling pathways, the activation of gene transcripts, and immune responses …
Thymic stromal lymphopoietin in cutaneous immune-mediated diseases
SH Wang, YG Zuo - Frontiers in Immunology, 2021 - frontiersin.org
Thymic stromal lymphopoietin (TSLP) was initially demonstrated to be critical in regulating
inflammatory responses among various allergic disorders (such as atopic dermatitis, food …
inflammatory responses among various allergic disorders (such as atopic dermatitis, food …
Neuropsychiatric systemic lupus erythematosus: molecules involved in its imunopathogenesis, clinical features, and treatment
AA Justiz-Vaillant, D Gopaul, S Soodeen… - Molecules, 2024 - mdpi.com
Systemic lupus erythematosus (SLE) is an idiopathic chronic autoimmune disease that can
affect any organ in the body, including the neurological system. Multiple factors, such as …
affect any organ in the body, including the neurological system. Multiple factors, such as …
Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
L Han, J Yan, T Li, W Lin, Y Huang, P Shen… - Frontiers in …, 2023 - frontiersin.org
Rheumatoid arthritis (RA) is a self-immune inflammatory disease characterized by joint
damage. A series of cytokines are involved in the development of RA. Oncostatin M (OSM) is …
damage. A series of cytokines are involved in the development of RA. Oncostatin M (OSM) is …
Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum
Objectives The difficulty of monitoring organ-specific pathology in systemic lupus
erythematosus (SLE) often complicates disease prognostication and treatment. Improved …
erythematosus (SLE) often complicates disease prognostication and treatment. Improved …
Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3
T He, Y Huang, Y Luo, Y Xia, LL Wang, H Zhang… - Journal of Clinical …, 2020 - Springer
Abstract Haploinsufficiency of A20 (HA20) is a newly described immune dysregulation
disease due to the loss-of-function mutation in TNFAIP3. In the present study, we report six …
disease due to the loss-of-function mutation in TNFAIP3. In the present study, we report six …
Genetically predicted circulating omega-3 fatty acids levels are causally associated with increased risk for systemic lupus erythematosus
P Wang, K Xiang, YY Xu, YS He, YQ Hu, J Ni… - Frontiers in …, 2022 - frontiersin.org
Background Accumulating evidence has demonstrated the associations of omega-3 or
omega-6 polyunsaturated fatty acids (PUFAs) with the disease activity and inflammatory …
omega-6 polyunsaturated fatty acids (PUFAs) with the disease activity and inflammatory …
From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures
S Namba, M Iwata, Y Yamanishi - Bioinformatics, 2022 - academic.oup.com
Motivation A critical element of drug development is the identification of therapeutic targets
for diseases. However, the depletion of therapeutic targets is a serious problem. Results In …
for diseases. However, the depletion of therapeutic targets is a serious problem. Results In …
Genetic factors in antiphospholipid syndrome: preliminary experience with whole exome sequencing
A Barinotti, M Radin, I Cecchi, SG Foddai… - International journal of …, 2020 - mdpi.com
As in many autoimmune diseases, the pathogenesis of the antiphospholipid syndrome
(APS) is the result of a complex interplay between predisposing genes and triggering …
(APS) is the result of a complex interplay between predisposing genes and triggering …